Clinical Trials Logo

Contact Dermatitis clinical trials

View clinical trials related to Contact Dermatitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04921163 Completed - Contact Dermatitis Clinical Trials

Children With Aluminium Contact Allergy: Oral Exposure Study

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Aluminium allergy is predominantly seen in children with small itchy nodules in the skin after vaccinations, so-called granulomas. We want to do an exposure study where aluminium allergic children have to eat aluminium pancakes for a short period of time. The purpose is to investigate whether a worsening of the children's symptoms can be detected, both itching of the granuloma, allergic rash on the skin and also the symptoms that are not measurable, such as headache, stomach ache and general agitation. We also want to examine the concentration of aluminium in the urine, which reflects the absorption of aluminum from the gastrointestinal tract.

NCT ID: NCT04772482 Completed - Dermatitis Clinical Trials

Study on Hypoallergenic Hair Dye

Start date: April 1, 2021
Phase:
Study type: Observational

Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein, we seek to decrease the risks of allergy to hair dyes by testing a novel version of p-phenylenediamine (PPD) with less allergy potential.

NCT ID: NCT04438135 Completed - Contact Dermatitis Clinical Trials

Children With Aluminium Contact Allergy: Cutaneous Exposure Study

Start date: June 10, 2020
Phase: N/A
Study type: Interventional

Aluminium is used in many different cosmetic products, including make-up, deodorants and sunscreen. The purpose of this study is to investigate whether these everyday skin products with small amounts of aluminium can cause skin reactions in children diagnosed with contact allergy to aluminium. The study is conducted as a Repeated Open Application Test study (ROAT), a method originally developed to clarify the clinical relevance of questionable and positive patch samples, by imitating everyday use of a skin product.

NCT ID: NCT03089775 Completed - Contact Dermatitis Clinical Trials

Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis

BBI
Start date: March 14, 2017
Phase: Phase 1
Study type: Interventional

This two cohort study (Cohort A and B) is being conducted to assess the safety and efficacy of BBI-2000 for the prevention (Cohort A) and treatment (Cohort B) of delayed type hypersensitivity reaction.

NCT ID: NCT02700373 Completed - Contact Dermatitis Clinical Trials

A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers

Start date: March 2016
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, single ascending dose study to assess the safety and tolerability of PDC-APB by intramuscular (IM) injection compared to placebo.

NCT ID: NCT02028208 Completed - Contact Dermatitis Clinical Trials

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

Start date: November 4, 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the diagnostic performance and safety of ascending doses of mercury, aluminum and palladium metal allergens proposed for inclusion in a metal allergen panel. Optimal dose will be selected based on the lowest dose of each allergen eliciting a positive response in 70-90% of subjects tested.

NCT ID: NCT02028182 Completed - Contact Dermatitis Clinical Trials

Clinical Evaluation of Lyral® Dose Response Study

Start date: February 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine optimal allergen dose as the lowest concentration eliciting positive reactions in 70-90% of subjects. Frequency of positive, negative, doubtful and irritant reactions, and concordance with a corresponding reference allergens will be captured.

NCT ID: NCT00824889 Completed - Melanoma Clinical Trials

Exploratory Study of Natural Killer Cells in Human Skin

Start date: February 2009
Phase: N/A
Study type: Interventional

Natural Killer (NK) cells play a unique role during innate immune responses as they are able to recognize and eliminate, without specific sensitization, tumors, microbe-infected cells as well as allogeneic cells.In a first time, we will characterize the tissue distribution, the phenotype and the effector functions of NK cells present in the human healthy skin.

NCT ID: NCT00646867 Completed - Contact Dermatitis Clinical Trials

Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

Start date: February 2008
Phase: N/A
Study type: Interventional

To determine if Tetrix Cream, when applied to the skin lesions on patients with contact dermatitis, improves the symptoms of burning and itching.

NCT ID: NCT00640614 Completed - Contact Dermatitis Clinical Trials

Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy

Start date: April 2008
Phase: Phase 3
Study type: Interventional

We propose an open, prospective, multi-center Phase III study to evaluate the diagnostic performance and safety of seven new T.R.U.E. Test allergens: Gold sodium thiosulfate, Hydrocortisone-17-butyrate, Bacitracin, Parthenolide, Methyldibromoglutaronitrile, Disperse blue 106, and Bronopol.Allergen performance and safety will be evaluated in adult patients with suspected contact dermatitis, and in adult patients with a known or suspected sensitization to at least one of the seven allergens.